Unitree’s IPO Debut: Shares Soared 629%—But the Robot Valuation Faces Real-World Risks

Unitree Robotics, formally known as Yushu Technology, delivered one of China’s most dramatic IPO debuts of 2026. On August 19, shares began trading on Shanghai’s STAR Market at RMB 1,100, compared with an IPO price of RMB 150.80. That represented a 629.44% gain. The stock later retreated and closed at RMB 845, still 460.34% above the offer price.

The move briefly valued the company at roughly RMB 445 billion, compared with about RMB 61 billion at the IPO price. By the close, its market capitalization was approximately RMB 341.8 billion.

The IPO at a glance

• IPO price: RMB 150.80 per share
• Opening price: RMB 1,100, up 629.44%
• Closing price: RMB 845, up 460.34%
• New shares issued: 40.446 million
• Share of enlarged company: 10%
• Funds raised: RMB 6.099 billion, or roughly $900 million
• IPO valuation: About RMB 61 billion, or approximately $9 billion
• Offer price-to-earnings ratio: About 219 times

The first-day rally was widely described in coverage as the largest IPO debut gain in China so far in 2026. It also established Unitree as the first humanoid-robot maker to list on a mainland Chinese exchange.

Retail investors showed extraordinary demand

Unitree’s IPO attracted unusually intense participation from individual investors. One exchange-filing report put the retail portion at 5,526 times subscribed, while Reuters reported demand of more than 8,000 times. Those figures should not be treated as perfectly interchangeable: they appear to describe different allocation categories or calculation methods. The consistent conclusion is that demand was exceptionally high.

The final online allotment rate was approximately 0.018%, according to reporting based on the offering announcement. Unitree therefore became a prominent test of how far investor enthusiasm for China’s humanoid-robot sector had run ahead of conventional valuation measures.

Founder Wang Xingxing and Meituan were major beneficiaries

The rally sharply increased the market value of founder Wang Xingxing’s holding. Chinese financial coverage calculated that his stake was worth more than RMB 133.5 billion at the opening price, prompting descriptions of Wang as the wealthiest member of China’s post-1990 generation. That is a mark-to-market estimate, not cash realized from a sale.

Meituan was also a major pre-IPO investor. Through three investment vehicles, it held approximately 35.1 million Unitree shares, or about 8.68% of the post-IPO company. At the IPO price, that holding was valued at roughly RMB 5.3 billion; the first-day surge pushed its paper value much higher.

As with Wang’s stake, these gains reflect the listed market price. They do not necessarily represent realized proceeds unless the holders sell, and lockups and trading conditions can affect when shares become transferable.

DeepSeek, Tencent and state-linked investors joined the strategic placement

Unitree’s strategic-placement investors included a mix of technology companies, state-linked institutions and financial investors. The disclosed participants included:

• DeepSeek’s operating entity, Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co.;
• Shanghai Qishan Investment, a Tencent-affiliated vehicle;
• China National Petroleum’s Kunlun Capital;
• Tianyi Capital, linked to China Telecom;
• Southern Grid-related capital;
• The National Social Security Fund;
• CITIC Securities Investment; and
• Unitree employee investment platforms.

The strategic placement covered approximately 8.089 million shares, or 20% of the IPO shares.

DeepSeek received 933,399 shares for about RMB 140.8 million. That represented 2.31% of the shares offered in the IPO and approximately 0.23% of Unitree’s post-IPO equity. Coverage based on the offering disclosures describes a 36-month lockup for DeepSeek’s strategic-placement shares.

The investment also carried strategic significance beyond its size. Unitree and DeepSeek were reported to be working together on AI models for humanoid robots, connecting Unitree’s physical platforms and deployment data with the development of embodied-intelligence systems.

Unitree’s business is growing, but the profit figures need context

Unitree’s 2025 revenue reached approximately RMB 1.70 billion, up from RMB 392.77 million in 2024. The company reported attributable net profit of RMB 278.21 million for 2025, while adjusted profit excluding certain non-recurring items was reported at roughly RMB 590.75 million. These are different measures and should not be combined as though they were the same earnings figure.

The company also reported more than 5,500 humanoid-robot shipments and more than 18,000 quadruped-robot sales in 2025. Omdia-based reporting estimated that roughly 15,000 humanoid robots were shipped globally that year; Unitree and AgiBot each shipped more than 5,000, placing both well ahead of reported U.S. competitors.

Those shipment figures help explain Unitree’s appeal. The company is not being valued solely as a conventional hardware manufacturer. Investors are also assigning value to its position in the emerging embodied-AI market: systems designed to perceive, reason and act in the physical world. The central question is whether impressive demonstrations and rising shipments will develop into repeatable, profitable industrial demand.

U.S. restrictions create a commercial ceiling

Unitree’s international growth faces meaningful geopolitical constraints. In late July, the U.S. Federal Communications Commission added foreign-made advanced robots to its Covered List, restricting the equipment authorization required for new models made outside the United States unless they receive an exemption or conditional approval. Unitree said existing humanoid and quadruped models had received FCC certification, but future models could face barriers to entering the U.S. market.

The Pentagon also added Unitree to its list of Chinese military companies in June, describing it as a contributor to China’s defense industrial base. Reuters reported that the designation is not a sanction, but it limits the U.S. military’s future use of Unitree technology.

The commercial exposure is significant because the United States accounted for roughly 13% of Unitree’s revenue, according to reporting based on the company’s disclosures.

Why the listing matters for China’s robot sector

Unitree’s debut gives public markets a highly visible valuation benchmark for humanoid-robot companies. A sustained price at or near the post-listing levels would support the fundraising and listing ambitions of other Chinese robotics firms. A sharp reversal, by contrast, would suggest that investors had priced in mass adoption before the industry had demonstrated durable commercial economics.

The scale of the valuation gap is the clearest warning. Unitree was valued at about RMB 61 billion at the offer price, then briefly reached approximately RMB 445 billion at the open before closing near RMB 342 billion. The stock’s first day therefore measured investor expectations more than it settled the company’s long-term worth.

JPMorgan has forecast that annual global humanoid-robot shipments could reach about 1 million by 2030. That is a market forecast, not evidence that current deployments have reached that scale or that today’s products will capture the market.

The investment case is still unproven

Unitree entered public trading with genuine operating momentum: rapidly rising revenue, reported profitability and leading shipment numbers. Its DeepSeek relationship also strengthens the narrative that robots could become platforms for embodied-intelligence models rather than standalone machines.

But the debut price embeds a much more ambitious future. Investors still need evidence that humanoid robots can perform reliable, economically useful work at scale; that Unitree can maintain profitability while funding research and development; and that geopolitical restrictions will not materially narrow its addressable market.

The most defensible reading of Unitree’s debut is therefore two-sided: it is a landmark for China’s robotics industry and a powerful signal of investor enthusiasm, but not yet proof that the humanoid-robot business has earned the valuation implied by its first trading day.